Myasthenia Gravis : An Invisible Battle that Deserves Greater Awareness ,By : Rusara Walisundara

 










Myasthenia Gravis : An Invisible Battle that 

    Deserves Greater Awareness 

 

     By : Rusara Walisundara 


     Teen Med Spot Research 


      7.16.2026














Myasthenia gravis is a chronic, long lasting neuromuscular disease that causes weakness in a person’s muscles. This autoimmune disease mistakenly attacks proteins at the connection between nerves and muscles that are needed for functioning individuals' daily lives, causing voluntary muscles to become weak more easily and lead to higher experiences of exhaustion. These muscles contract body parts essential for breathing, swallowing and facial movements, it can include biceps, quadriceps, abdominals. Since myasthenia gravis is known as a rare disease, it is uncommon amongst the general population. In the United States, it affects fewer than 200,000 people, and roughly 150 to 250 people per million worldwide.  It can affect people of all ages, but most commonly young adult women and older men. Animals such as dogs can develop myasthenia gravis too. Despite being rare, society should learn how this disease needs more acknowledgement as it leads to life-threatening situations. Invisible fluctuating muscle weakness can serve as a prototype for dedicated research and medical service. There is relevant information that encourages higher awareness for the disease and its overall influence, but more so clearer research that should be studied. Myasthenia gravis is an autoimmune disease so there isn't a direct start for this weakness and fatigue amongst society. 


Most women under age 40 and men over age 60 are more commonly affected with this disease compared to other categories, infants are unlikely to be affected (Harvard Health Publishing, 2018). It is not directly inherited or contagious. However, the disease is strongly associated with abnormalities of the thymus gland, the small gland in the upper chest. Some adults with myasthenia gravis have an abnormally large thymus gland, while others may have a thymoma. Other autoimmune conditions such as lupus can also influence multiple organs rather than specific targets of nerves and muscles. 

Individuals coping with myasthenia gravis experience symptoms that can alter their daily lives. Muscle weakness is highly varied amongst individuals. For instance, the Myasthenia Gravis Foundation of America states how various people that participate in strength training or sports may experience challenges because repetitive muscle use can worsen strength. Experiencing weakness in arms, fingers, hands, legs, and neck. Conversely, exercise does not lead to myasthenia gravis. Although, if symptoms are controlled and pace is managed, moderate exercise can be beneficial to help maintain strength, endurance, and overall physical function, endurance, and overall fight off tiredness. Symptoms can consist of issues with the eyes, such as weakness of the eye muscles, dropping of eyelids, and troubled vision. (National Institute of Neurological Disorders and Stroke, 2024). Also complications when communicating, including changes in facial expressions and impaired speech, and normal activities of difficulty swallowing and shortness of breath.

Patients of different ages are impacted differently from this. As noted earlier, athletes or people going to the gym may have obstacles with working out and fulfilling their workout goals. In addition to physical effects, younger individuals have challenges with school, work, and other basic activities. Emotional effects such as anxiety or depression play a role too. Animals, mostly dogs also face decreased muscle control and worsen in physical activity (Myasthenia Gravis, 2026). Many patients experience myasthenic crisis, a life-threatening risk where the muscles become so weak that it hinders the patient’s breathing abilities, requiring immediate emergency medical attention and ventilation. It’s triggered by infection, stress, surgery, or an adverse reaction to medication, although some crises may have no identifiable trigger.

Diagnosis for myasthenia gravis is identified through physical examination and specific blood tests that identify harmful antibodies, electrodiagnostic tests, and chest imaging of CT or MRI scans to check the thymus. Diagnosis includes ice pack tests for drooping eyelids as well (Mayoclinic, 2023). 

Some treatments for myasthenia gravis consist of different pain tolerance and side effects that vary by patients. For instance, the plasma exchange and intravenous immunoglobulin during severe flare-ups (Myasthenia Gravis, 2026). The process may involve IV catheter insertion, plasma exchange involves filtering plasma from the blood, while intravenous immunoglobulin involves receiving antibodies from healthy donors, large-volume blood filtering, and lengthy clinic visits which can be physically taxing. Treatments could be considered invasive and uncomfortable. Thymectomy, the removal of the thymus gland, is a surgical procedure that alters the immune system, leading to long-term remission for some patients. 

More medications include specifically suppressing the immune system, this consists of immunosuppressive drugs and corticosteroids. Immunosuppressive drugs are used to suppress the faulty immune response and corticosteroids are used to rapidly decrease the immune system's attack. Another medication, pyridostigmine, can help improve communication between nerves and muscles. Further supportive care can also be strategies such as physical therapy helping patients manage daily fatigue and develop safe activity plans. Patients often work with physical therapists to develop safe exercise plans. According to the National Institute of Neurological Disorders and Stroke, approximately 15-20% of people with myasthenia gravis experience at least one myasthenic crisis and up to 50% of those may not be able to identify a trigger for their myasthenic crisis (3). 

Current research reveals data informing new biologic medications, more targeted immune therapies, and studies on improving quality of life and long-term outcomes. Beyond traditional treatments, AI research in myasthenia gravis focuses on technology contributions, researchers use computer vision to analyze patient videos and track fluctuations in physical symptoms even from lower quality recordings (MDA Conference, 2026). Other technology advancements such as AI-assisted tools accurately track ptosis, drooping eyelids, and facial weakness via patient selfies. Moreover, prognostic modeling further assists myasthenia gravis by predicting severe outcomes like myasthenic crises and hospital length of stay. 

When myasthenia gravis reduces strength in one's muscles, many patients have antibodies against acetylcholine receptors, which interfere with communication between nerves and muscles. It is crucial to make sure there are faster diagnoses and urgent patient support for better outcomes. Since myasthenia gravis is rare amongst society, symptoms aren't always clear, patients frequently face invisible indications like stress or tiredness, masked by the general public as normal symptoms. Ultimately, myasthenia gravis has no straight cure, but more funding into research and future treatments could potentially guide society to a cure, but mostly respected recognition.  









Sources 

  • Harvard Health Publishing. (2018, December 19). Myasthenia Gravis - Harvard Health. Harvard Health; Harvard Health. https://www.health.harvard.edu/a_to_z/myasthenia-gravis-a-to-z

  • Artificial Intelligence-Powered Telemedicine Tool Automates Scoring of Neuromuscular Examinations in Myasthenia Gravis. (2024). Rare Diseases Clinical Research Network. https://www.rarediseasesnetwork.org/news/consortium-impact-features-research-feature/2024-10/artificial-intelligence-powered

  •  Mdaconference.Org. (2026) https://www.mdaconference.org/abstract-library/looking-into-the-future-of-myasthenia-gravis-management-using-artificial-intelligence/

  • What is Myasthenia Gravis? | Myasthenia Gravis Foundation of America. (2024, October 2). Myasthenia Gravis Foundation of America. https://myasthenia.org/understanding-mg/what-is-myasthenia-gravis/

  • National Institute of Neurological Disorders and Stroke. (2024). Myasthenia gravis. Www.Ninds.Nih.Gov. https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis

  • Mayo Clinic. (2023). Myasthenia gravis - Diagnosis and treatment - Mayo Clinic. Mayoclinic.Org. https://www.mayoclinic.org/diseases-conditions/myasthenia-gravis/diagnosis-treatment/drc-20352040

  • Myasthenia gravis. (2026). Cornell University College of Veterinary Medicine. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/myasthenia-gravis

Comments

Post a Comment

Popular posts from this blog

Understanding Ehlers-Danlos Syndrome (EDS) By: Zella Shanks (Current Campaign)

Image
  Introduction   What is Ehlers-Danlos Syndrome (EDS)? Ehlers-Danlos Syndrome, also known as EDS, is a group of genetic disorders that affect the body’s connective tissues. Connective tissue is found almost everywhere in the body and helps hold everything together, including your own skin, joints, muscles, and blood vessels. People that have Ehlers-Danlos Syndrome have problems with collagen, which is one of the many main proteins that gives connective tissues its strength and flexibility. When collagen doesn’t work the way it’s supposed to, the body’s tissues become weaker and more likely to stretch or to get injured. Why Is It Important?    Even though EDS isn’t very well known, it can have a huge effect on someone’s everyday life. Many people deal with ongoing pain, fatigue, joint injuries, and other symptoms that can make normal activities more difficult. While there isn’t a cure yet, getting diagnosed early and learning how to manage the condition can ...
Read more

Uncovering the Clinical Characterization and Mechanisms of Fibrodysplasia Ossificans Progressiva (FOP) By: Sharen Rego

Image
 Introduction Fibrodysplasia Ossificans Progressiva or FOP is an exceedingly rare, yet severely disabling genetic disorder, characterized by the abnormal formation of bone tissue outside of the normal human skeleton (heterotopic ossification). This can occur within soft tissues like the skeletal muscles, tendons, and ligaments. With an estimated one in two million people affected globally, FOP represents one of the most complex genetic conditions known to modern medicine. Raising awareness for this disorder is crucial, as early symptoms are often misdiagnosed as cancer, leading to harmful medical interventions like biopsies or routine muscle injections which trigger irreversible bone growth. Main Body At the cellular level, FOP is caused by a specific mutation in the ACVR1 gene located on chromosome 2. This gene provides instructions for making a specialized receptor protein that controls when and where the body builds bone tissue (such as during fetal development or when healing a...
Read more

Understanding Cystic Fibrosis

Image
Blog written by Alyza Kour - Reasearch Lead of Teen Med Spot   Mucus in our body is more than just “gross stuff” coming out our nose when we have a cold, it’s actually a vital protective layer. Its job is to line our lungs, digestive tract, and other organs to keep them moist and to trap dust, bacteria, or virusese so your body can get rid of them. Healthy mucus is thin, slippery, and water (Think of it like a layer of liquid soap). ( Cleveland Clinic ) What is cystic fibrosis? It is a genetic disease that causes sticky, thick mucus to build up in your organs (Lungs, Digestive System, Pancreas), blocking and damaging them. ( Cleveland Clinic.org ) What causes cystic fibrosis? Changes to the CFTR gene - called variants or mutations - cause cystic fibrosis. CFTR makes a protein that works as an ion channel on the surface of a cell. Ion channels are like gates in a cell’s membrane that allow certain molecules to pass through. Think of this protein as a “gate” for chloride ions (sa...
Read more